Post‐Translational Isoaspartate Promotes Amyloid Formation in β2‐Microglobulin
Ryuji Kawakami, Toshiki Takei, Masatomo So, Toshifumi Takao, Yoshinori Taguchi, Hironobu Hojo · 2026
Read Post‐Translational Isoaspartate Promotes Amyloid Formation in β2‐Microglobulin by Ryuji Kawakami, Toshiki Takei, Masatomo So, Toshifumi Takao, Yoshinori Taguchi, Hironobu Hojo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13383051.txt.
Description
Kawakami and colleagues provide the first test of whether a spontaneous chemical change in a protein can trigger amyloid disease, in 2026 protein research. The protein, beta2-microglobulin, builds up in long-term dialysis patients and forms amyloid fibrils that damage joints, a condition called dialysis-related amyloidosis. An age-related change, isoaspartate formation, was suspected but untestable because chemists could not build the modified protein. The team built variants carrying the change at the two hotspots, positions 17 and 42.
The isoaspartate-17 variant formed fibrils even more readily than the known pathogenic truncated variant. Microscopy and spectroscopy confirmed amyloid fibrils. The position-42 variant did not share that potency, localizing the effect to one specific aging site on the protein. Kawakami argues it is a general driver of pathological protein aggregation, and casts the disease as one of accumulated damage that healthy kidneys would normally clear.
Catalog record
| CREATOR | Ryuji Kawakami, Toshiki Takei, Masatomo So, Toshifumi Takao, Yoshinori Taguchi, Hironobu Hojo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |